- Terex Corporation (NYSE:TEX) said its Board of Directors authorized a new share repurchase program of up to $150 million.
- The new authorization is in addition to the share repurchase program announced in July 2018, under which $43 million is remaining.
- The repurchase program may be executed through various methods, including open market purchases.
- The program has no termination date and may be suspended or discontinued at any time.
- The company held $231.7 million in cash and equivalents as of Sept. 30, 2022.
- Price Action: TEX shares are trading higher by 2.49% at $42.58 on the last check Monday.
- Photo Via Company
Reata Pharmaceuticals Q3 EPS $(1.27) Up From $(1.31) YoY, Sales $7.40M Up From $1.40M YoY
Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.27) per share. This is a 3.05 percent increase over losses of $(1.31) per share from the same period last year. The company reported $7.40 million in
